- Overview
-
I am interested in exploring whether certain functional placental structures and their location and timing of development are factors in normal pregnancy outcome. Conversely, I am also interested in identifying specific placental development factors that are associated with poor pregnancy outcomes or long term health problems.
- Research
-
Current project
Ongoing collaborative work with colleagues at the University of Ottawa is aimed at developing standardized “synoptic” templates for placental pathology reporting.Current Project
Ongoing collaborative work is aimed at defining objective tests or measurements to distinguish constitutionally small from growth restricted fetuses. This work is being done as part of a multidisciplinary and multi-institutional study including the maternal-fetal medicine and pathology divisions at BC Children's and Women's Hospital and The Ottawa Hospital. This study seeks to correlate results of rests that are done in pregnancy including ultrasounds and Doppler as well as novel testing for proteins in the maternal serum (angiogenic growth factors) with placental pathology.
Government of Canada invests $20 million to improve health outcomes of children living with rare diseases
The Government of Canada is providing $20 million over five years for the creation of RareKids-CAN: Pediatric Rare Disease Clinical Trials and Treatment Network. This national network, of which BCCHR will be a part, will support national and international clinical trials to advance discoveries, enable better prevention, diagnosis, and treatments, to improve health outcomes for children and adolescents affected by rare diseases.